Skip to main content
Clinical Trials/IRCT20190210042676N18
IRCT20190210042676N18
Recruiting
Phase 2

Clinical evaluation of the safety and effectiveness Oral capsules (containing minoxidil, finasteride and biotin) in the prevention and treatment of androgenic hair loss

Knowledge-based company of Janus0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Knowledge-based company of Janus
Enrollment
20
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Knowledge-based company of Janus

Eligibility Criteria

Inclusion Criteria

  • Male aged 18\-50 years
  • General health
  • Hair Loss Status II, III, IV Based on Norwood Scale
  • Voluntary participation and signing written informed consent

Exclusion Criteria

  • Chronic active scalp disease other than hair loss
  • Using any prescribed drug or OTC for hair loss within the past 3 months
  • Documented sensitivity to formulation components
  • Any severe weight loss or strict diet therapy during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials